Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:176-179
doi: 10.1161/01.CIR.0000019361.34897.75
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soejima, K.
Right arrow Articles by Stevenson, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soejima, K.
Right arrow Articles by Stevenson, W. G.
Related Collections
Right arrow Ablation/ICD/surgery

(Circulation. 2002;106:176.)
© 2002 American Heart Association, Inc.


Clinician Update

Ventricular Tachycardia Associated With Myocardial Infarct Scar

A Spectrum of Therapies for a Single Patient

Kyoko Soejima, MD; William G. Stevenson, MD

From the Cardiovascular Division, Department of Internal Medicine, Brigham and Women’s Hospital, and Harvard Medical School, Boston, Mass.

Correspondence to William G. Stevenson, MD, Cardiovascular Division, Brigham and Women’s Hospital 75 Francis St, Boston, MA 02115. E-mail wstevenson@partners.org


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Case: A 73-year-old woman is referred for management of recurrent ventricular tachycardia (VT). She had suffered an inferior wall myocardial infarction in 1970. Fifteen years later, she presented with a wide QRS tachycardia, palpitations, and dizziness. Therapy with amiodarone was initiated but discontinued in 1997 because of toxicity, and she received an implantable cardioverter-defibrillator (ICD). She did well until July 2000, when she had several shocks from the ICD, all of which were preceded by syncope. Interrogation of the ICD confirmed 23 episodes of VT, 20 asymptomatic runs terminated by antitachycardia pacing (ATP), and 3 episodes requiring cardioversion from the ICD. Her left ventricular ejection fraction was 25%. Sotalol failed to prevent VT recurrences and mexiletine produced nausea and tremor.

She was referred for catheter ablation. An echocardiogram revealed akinesis of the inferior wall and no left ventricular thrombus. In the electrophysiology laboratory, programmed stimulation induced 5 different morphologies of VT (Figure 1) with rates ranging from 180 to 220 bpm. Because the induced VTs were unstable, producing hypotension and often changing from one VT to another, catheter mapping and ablation were performed largely during sinus rhythm, guided by electrogram characteristics and pacing during sinus rhythm (pace-mapping) that marked the location of the infarct scar and likely reentry paths in the subendocardium. After placement of lines of radiofrequency (RF) lesions through these abnormal regions, only ventricular flutter (280 bpm) was inducible; the slower VTs were no longer inducible. There have been no VT recurrences in the 18 months . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Journal of Bioactive and Compatible PolymersHome page
T. Ranne, T. Tirri, A. Yli-Urpo, T.O. Narhi, V.J.O. Laine, J. Rich, J. Seppala, and A. Aho
In Vivo Behavior of Poly(isin-Caprolactone-co-DL-Lactide)/Bioactive Glass Composites in Rat Subcutaneous Tissue
Journal of Bioactive and Compatible Polymers, May 1, 2007; 22(3): 249 - 264.
[Abstract] [PDF]


Home page
Crit Care NurseHome page
J. Zak
Mapping Ventricular Tachycardia
Crit. Care Nurse, October 1, 2006; 26(5): 13 - 20.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. H.L. Tang, S. Fazel, R. D. Weisel, G. S. Van Arsdell, and R.-K. Li
Cardiovascular Tissue Engineering Therapy: So Near, So Far?
Ann. Thorac. Surg., June 1, 2005; 79(6): 1831 - 1833.
[Full Text] [PDF]


Home page
RadiologyHome page
C. Riviere, F. P. Boudghene, F. Gazeau, J. Roger, J.-N. Pons, J.-P. Laissy, E. Allaire, J.-B. Michel, D. Letourneur, and J.-F. Deux
Iron Oxide Nanoparticle-labeled Rat Smooth Muscle Cells: Cardiac MR Imaging for Cell Graft Monitoring and Quantitation
Radiology, June 1, 2005; 235(3): 959 - 967.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
A Rashid and D Ivy
Severe paediatric pulmonary hypertension: new management strategies
Arch. Dis. Child., January 1, 2005; 90(1): 92 - 98.
[Abstract] [Full Text] [PDF]